NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
14.30
-0.50 (-3.38%)
Jan 31, 2025, 4:00 PM EST - Market closed
NeoGenomics Employees
NeoGenomics had 2,100 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$306,723
Profits / Employee
-$37,013
Market Cap
1.84B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
NEO News
- 3 days ago - NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 - Business Wire
- 17 days ago - NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan - Business Wire
- 22 days ago - NeoGenomics Announces Chief Executive Officer Succession - Business Wire
- 26 days ago - NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 7 weeks ago - NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma - Business Wire
- 7 weeks ago - NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting - Business Wire
- 2 months ago - ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research - Business Wire
- 2 months ago - NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Business Wire